Innovative Delivery Platform Intrommune's development of a unique tooth brushing-based immunotherapy platform offers an engaging and convenient treatment approach, creating opportunities to partner with oral health providers, dental clinics, and wellness brands interested in expanding their patient-centered solutions.

Growing Market Focus With an addressable market of over 220 million people suffering from food allergies worldwide, there is significant expansion potential for partnerships, licensing, and distribution agreements targeting both healthcare providers and consumer markets.

Leadership Expansion Recent appointments of experienced industry leaders to the board and executive team signal growth and strategic direction, making the company a promising partner for investors, research collaborations, and commercial alliances in biotech and allergy treatment sectors.

Product Pipeline Development Intrommune’s development of multiple products including toothpaste and immunotherapy treatments presents opportunities to explore retail, consumer health, and pharmaceutical distribution channels for different consumer segments.

Funding and Revenue Potential While current revenue is modest, the company's promising treatment platform and ongoing product launches suggest strong upside for sales partners and stakeholders looking to capitalize on innovative allergy therapies in a growing biotech landscape.